Article

Tuberculous peritonitis after treatment with adalimumab.

Internal Medicine, San Carlos Clinic Hospital, Madrid, Spain.
Scandinavian Journal of Infectious Diseases (impact factor: 1.72). 02/2008; 40(8):677-8. DOI:10.1080/00365540701877320
Source: PubMed

ABSTRACT We present a case of tuberculous peritonitis in a woman with rheumatoid arthritis (RA), treated with adalimumab, and we review the association between anti-tumour necrosis factor (anti-TNF) therapy and tuberculosis. There have been only 2 case reports of peritoneal tuberculosis associated with anti-TNF and only 1 with adalimumab.

0 0
 · 
0 Bookmarks
 · 
43 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

adalimumab
 
anti-TNF
 
anti-tumour necrosis factor
 
rheumatoid arthritis
 
tuberculous peritonitis
 

Jose Antolín